Glenmede Trust CO Na Dr Reddys Laboratories LTD Transaction History

Glenmede Trust CO Na

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$64.27 - $69.9 $195,380 - $212,496	3,040 New	3,040 $211,000
Q4 2020 Feb 16, 2021	SELL	$62.61 - $71.29 $84,273 - $95,956	-1,346 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$51.39 - $72.41 $6,989 - $9,847	-136 Reduced 9.18%	1,346 $93,000
Q2 2020 Aug 14, 2020	BUY	$39.55 - $54.65 $9,729 - $13,443	246 Added 19.9%	1,482 $78,000
Q3 2019 Nov 14, 2019	BUY	$34.82 - $39.26 $11,595 - $13,073	333 Added 36.88%	1,236 $46,000
Q2 2019 Aug 13, 2019	SELL	$36.05 - $42.76 $1,117 - $1,325	-31 Reduced 3.32%	903 $33,000
Q1 2019 May 14, 2019	SELL	$35.77 - $40.57 $250 - $283	-7 Reduced 0.74%	934 $37,000
Q4 2018 Feb 14, 2019	BUY	$31.89 - $38.44 $30,008 - $36,172	941 New	941 $35,000
Q2 2018 Aug 15, 2018	SELL	$28.49 - $35.06 $20,883 - $25,698	-733 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$34.15 - $37.62 $9,186 - $10,119	269 Added 57.97%	733 $27,000
Q3 2017 Nov 14, 2017	BUY	$30.11 - $37.72 $13,971 - $17,502	464	464 $0

233

24M

14.6K

2.8K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $13.2B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.